Literature DB >> 24167531

In reply.

Jürg Barben.   

Abstract

Mesh:

Year:  2013        PMID: 24167531      PMCID: PMC3804782          DOI: 10.3238/arztebl.2013.0676b

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  5 in total

1.  Retrospective analysis of stored dried blood spots from children with cystic fibrosis and matched controls to assess the performance of a proposed newborn screening protocol in Switzerland.

Authors:  Juerg Barben; Sabina Gallati; Ralph Fingerhut; Martin H Schoeni; Matthias R Baumgartner; Toni Torresani
Journal:  J Cyst Fibros       Date:  2012-02-01       Impact factor: 5.482

2.  Psychological effects of false-positive results in cystic fibrosis newborn screening: a two-year follow-up.

Authors:  Julie Beucher; Emmanuelle Leray; Eric Deneuville; Monique Roblin; Isabelle Pin; François Bremont; Dominique Turck; Jean-Louis Giniès; Pascal Foucaud; Gilles Rault; Jocelyne Derelle; Valérie David; Hubert Journel; Sophie Marchand; David Veillard; Michel Roussey
Journal:  J Pediatr       Date:  2010-02-20       Impact factor: 4.406

3.  Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study.

Authors:  Erika J Sims; Miranda Mugford; Allan Clark; David Aitken; Jonathan McCormick; Gita Mehta; Anil Mehta
Journal:  Lancet       Date:  2007-04-07       Impact factor: 79.321

4.  Newborn screening for cystic fibrosis: evidence for benefit.

Authors:  Ian M Balfour-Lynn
Journal:  Arch Dis Child       Date:  2008-01       Impact factor: 3.791

5.  One-year evaluation of a neonatal screening program for cystic fibrosis in Switzerland.

Authors:  Corina S Rueegg; Claudia E Kuehni; Sabina Gallati; Matthias Baumgartner; Toni Torresani; Juerg Barben
Journal:  Dtsch Arztebl Int       Date:  2013-05-17       Impact factor: 5.594

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.